ArticleNature communications2021
Revisiting species and areas of interest for conserving global mammalian phylogenetic diversity.
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Synergies and trade-offs for reaching global biodiversity and climate commitments.Nature communications · 2026Article
- Global increase in the endemism of birds from north to south.Nature communications · 2025Article
- Conservation priorities for functionally unique and specialized terrestrial vertebrates threatened by biological invasions.Conservation biology : the journal of the Society for Conservation Biology · 2025Article
- The socioeconomic and environmental niche of protected areas reveals global conservation gaps and opportunities.Nature communications · 2024Article
- Advancing EDGE Zones to identify spatial conservation priorities of tetrapod evolutionary history.Nature communications · 2024Article
- Global conservation status of the jawed vertebrate Tree of Life.Nature communications · 2024Article
- The EDGE2 protocol: Advancing the prioritisation of Evolutionarily Distinct and Globally Endangered species for practical conservation action.PLoS biology · 2023Article
- Phylogenetic diversity in conservation: A brief history, critical overview, and challenges to progress.Cambridge prisms. Extinction · 2023Review
- Dietary isotopes of Madagascar's extinct megafauna reveal holocene browsing and grazing guilds.Biology letters · 2022Article
- Global determinants and conservation of evolutionary and geographic rarity in land vertebrates.Science advances · 2021Article
- Revisiting species and areas of interest for conserving global mammalian phylogenetic diversity.Nature communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various prioritisation strategies have been developed to cope with accelerating biodiversity loss and limited conservation resources. These strategies could become more engaging for decision-makers if they reflected the positive effects conservation can have on future projected biodiversity, by targeting net positive outcomes in future projected biodiversity, rather than reflecting the negative consequences of further biodiversity losses only. Hoping to inform the post-2020 biodiversity framework, we here apply this approach of targeting net positive outcomes in future projected biodiversity to phylogenetic diversity (PD) to re-identify species and areas of interest for conserving global mammalian PD. We identify priority species/areas as those whose protection would maximise gains in future projected PD. We also identify loss-significant species/areas as those whose/where extinction(s) would maximise losses in future projected PD. We show that our priority species/areas differ from loss-significant species/areas. While our priority species are mostly similar to those identified by the EDGE of Existence Programme, our priority areas generally differ from previously-identified ones for global mammal conservation. We further highlight that these newly-identified species/areas of interest currently lack protection and offer some guidance for their future management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.